心房纤颤(房颤,AF)是最常见的心律失常之一,发病率随年龄的增加而增加,其主要危害是增加血栓栓塞事件,并且影响患者的生活质量,Framingham心脏研究[1]发现经年龄和心血管疾病危险因素校正后,房颤仍是死亡率增加的危险因素,因此需高度重视对房颤的治疗。房颤的治疗主要包括药物治疗和非药物治疗两个方面,其中非药物治疗方面导管消 Atrial fibrillation (atrial fibrillation, AF) is one of the most common arrhythmia, the incidence increases with age, the main harm is to increase thromboembolic events, and affect the quality of life of patients, the Framingham Heart Study [1] found After adjusting for age and cardiovascular risk factors, atrial fibrillation is still a risk factor for increased mortality, so a high degree of attention to the treatment of atrial fibrillation. The treatment of atrial fibrillation include drug treatment and non-drug treatment in two aspects, including non-drug treatment catheter disappear